Cargando…
Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis
We investigated major determinants of the intracellular concentrations of methotrexate polyglutamates (MTXPGs) in patients with rheumatoid arthritis (RA). In 271 RA patients on stable oral low dose weekly pulse MTX therapy, the concentrations of MTXPGs in red blood cells (RBCs) were measured by liqu...
Autores principales: | Yamamoto, Tatsuhiro, Shikano, Kotaro, Nanki, Toshihiro, Kawai, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067511/ https://www.ncbi.nlm.nih.gov/pubmed/27752107 http://dx.doi.org/10.1038/srep35615 |
Ejemplares similares
-
Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
por: Hobl, Eva-Luise, et al.
Publicado: (2010) -
Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis
por: Muller, Ittai B, et al.
Publicado: (2020) -
Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study
por: Takahashi, Chihiro, et al.
Publicado: (2017) -
Efficacy of Denosumab for Osteoporosis in Patients with Rheumatic Diseases
por: Kaneko, Kaichi, et al.
Publicado: (2022) -
A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis
por: van de Meeberg, Maartje M., et al.
Publicado: (2022)